X4 Pharmaceuticals Stock (NASDAQ:XFOR), Quotes and News Summary

Q: What sector and industry does X4 Pharmaceuticals (XFOR) operate in?

X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

X4 Pharmaceuticals Stock (NASDAQ: XFOR) stock price, news, charts, stock research, profile.

Open	$1.140
Close	$1.165
Volume / Avg.	11.130M / 2.454M
Day Range	0.900 - 1.240
52 Wk Range	0.572 - 2.575
Market Cap	$199.846M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	7.36%
Days to Cover	2.21

Recent News

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.

Avi Kapoor

Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some other stocks moving in pre-market trading.

Avi Kapoor

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet

Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming.

Chris Katje

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About X4 Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research an...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy X4 Pharmaceuticals (XFOR) stock?

You can purchase shares of X4 Pharmaceuticals (NASDAQ: XFOR) through any online brokerage.

View our list of the best stock brokerages.

Who are X4 Pharmaceuticals's (XFOR) competitors?

Other companies in X4 Pharmaceuticals’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Adverum Biotechnologies (NASDAQ:ADVM), bluebird bio (NASDAQ:BLUE) and Atossa Therapeutics (NASDAQ:ATOS).

What is the target price for X4 Pharmaceuticals (XFOR) stock?

The latest price target for X4 Pharmaceuticals (NASDAQ: XFOR) was reported by HC Wainwright & Co. on Friday, March 22, 2024. The analyst firm set a price target for 3.00 expecting XFOR to rise to within 12 months (a possible 152.10% upside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for X4 Pharmaceuticals (XFOR)?

The stock price for X4 Pharmaceuticals (NASDAQ: XFOR) is $1.19 last updated Today at April 26, 2024 at 7:24 PM EDT.

Does X4 Pharmaceuticals (XFOR) pay a dividend?

There are no upcoming dividends for X4 Pharmaceuticals.

When is X4 Pharmaceuticals (NASDAQ:XFOR) reporting earnings?

X4 Pharmaceuticals’s Q1 earnings are confirmed for Friday, May 10, 2024.

Is X4 Pharmaceuticals (XFOR) going to split?

There is no upcoming split for X4 Pharmaceuticals.

What sector and industry does X4 Pharmaceuticals (XFOR) operate in?

X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-